''For several years a company initially called Advanced Magnetics (and later known as AMAG Pharma), with its partners, spent a good deal of money developing and seeking approval of a product called ferumoxtran-10. Ferumoxtran-10 was an imaging agent ...'
''Authorisation Application (MAA) for Sinerem, a new contrast agent for MRI. The Sinerem MAA had been submitted to the EMEA (European Medicines Agency) in November 2006 for the detection and characterisation of metastatic lymph nodes in pelvic ...'
Saturday, 13 December 2008 by www.prnewswire.co.uk
''I would like to inform you that, at this point of time, Guerbet has taken the decision to withdraw the application for Marketing Authorisation of Sinerem ...'
•
News
top
